11.15.24 -- 3 Focus Areas To Transition From Clinical To Commercial Readiness

Learn why blow-fill-seal technology has been gaining increasing worldwide acceptance in the parenteral drug marketplace, replacing traditional glass vial processing in a growing number of applications.

How do you choose the right X-ray inspection system? This guide outlines everything you need to know to select a system to meet your detection goals in a way that maximizes ROI and OEE.

Uncover how automation and real-time monitoring across all process steps provide the rapid response and control needed for successful continuous manufacturing.

As demand for capabilities and resources grows throughout a project, both become strained in-house and the scale-up process becomes a steeper hill to climb.

Learn about a platform for creating injectable and implantable long-acting drug delivery products, including its technical basics and how it can be used to deliver small molecules, peptides, and biologics.

A team of experts discuss risk-reduction strategies, critical formulation considerations, and careful technology selection to stretch the often limited quantities of API available for early studies.

In a rapidly evolving industry, see why adopting digital solutions is essential for achieving operational excellence and staying competitive.

Gain insights into a “simul-spray” process pioneering for combining small and large molecules into a single, atomized drug product for inhalation administration.

Here, we provide systematic methods to increase return on investment. Discover the seven primary investment recovery channels.

A new algorithm developed by a real-time viable particle counter determines the viability of a particle based on its measured optical properties, improving the detection of microorganisms.

Learn how modern advancements can improve the efficiency of microbial air sampling while minimizing the chances of false positives in cleanrooms.

Srinivasan Shanmugam, Ph.D., Executive Director of Pharmaceutical Sciences at Adare, discusses pediatric patient compliance, regulations impacting trial access, excipients within formulations, and more.

The pharmaceutical industry is undergoing a transformative shift from batch to continuous flow processes, enabling enhanced efficiency and safety as well as improved sustainability.

Explore the current trends and challenges with manufacturing high-concentration drug products and an approach to performing extensive filterability trials without a high quantity of expensive product.

Bilayer tablets offer a number of benefits for patient care; understanding the challenges that accompany their formulation is key to enabling their successful commercialization.